US lawmakers are again expressing worries about GenScript's ties to China. The concerns involve national security and intellectual property risks.
U.S. lawmakers are raising renewed concerns regarding the connections between GenScript Biotech and China. This scrutiny highlights ongoing worries about the relationship between American and Chinese companies, especially in sensitive sectors.
The central issues revolve around potential national security implications and the risk of intellectual property theft arising from these collaborations. Lawmakers are evaluating the depth and breadth of these ties to determine if they pose a threat to U.S. interests.
The developments underscore the heightened vigilance surrounding U.S.-China relations and the imperative to safeguard critical technologies and intellectual property.